nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—Snoring—Donepezil—Alzheimer's disease	0.0695	0.23	CcSEcCtD
Etomidate—SLC2A1—blood vessel—Alzheimer's disease	0.0323	0.156	CbGeAlD
Etomidate—SLC2A1—embryo—Alzheimer's disease	0.0193	0.0933	CbGeAlD
Etomidate—SLC2A1—forebrain—Alzheimer's disease	0.0171	0.0825	CbGeAlD
Etomidate—SLC2A1—telencephalon—Alzheimer's disease	0.0157	0.0759	CbGeAlD
Etomidate—Myoclonus—Memantine—Alzheimer's disease	0.0152	0.0503	CcSEcCtD
Etomidate—Myoclonus—Rivastigmine—Alzheimer's disease	0.0149	0.0493	CcSEcCtD
Etomidate—Hyperventilation—Donepezil—Alzheimer's disease	0.0146	0.0485	CcSEcCtD
Etomidate—Hyperventilation—Rivastigmine—Alzheimer's disease	0.013	0.0431	CcSEcCtD
Etomidate—Hiccups—Galantamine—Alzheimer's disease	0.013	0.043	CcSEcCtD
Etomidate—Apnoea—Memantine—Alzheimer's disease	0.0108	0.0357	CcSEcCtD
Etomidate—Apnoea—Rivastigmine—Alzheimer's disease	0.0106	0.035	CcSEcCtD
Etomidate—Respiratory failure—Memantine—Alzheimer's disease	0.00932	0.0308	CcSEcCtD
Etomidate—SLC2A1—nervous system—Alzheimer's disease	0.00926	0.0448	CbGeAlD
Etomidate—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00911	0.0302	CcSEcCtD
Etomidate—Hiccups—Rivastigmine—Alzheimer's disease	0.00895	0.0296	CcSEcCtD
Etomidate—SLC2A1—central nervous system—Alzheimer's disease	0.00891	0.0431	CbGeAlD
Etomidate—SLC2A1—cerebellum—Alzheimer's disease	0.00871	0.0422	CbGeAlD
Etomidate—SLC2A1—brain—Alzheimer's disease	0.00708	0.0342	CbGeAlD
Etomidate—GABRG2—forebrain—Alzheimer's disease	0.00665	0.0322	CbGeAlD
Etomidate—GABRB2—forebrain—Alzheimer's disease	0.00665	0.0322	CbGeAlD
Etomidate—Bradycardia—Galantamine—Alzheimer's disease	0.00665	0.022	CcSEcCtD
Etomidate—GABRB2—telencephalon—Alzheimer's disease	0.00612	0.0296	CbGeAlD
Etomidate—GABRG2—telencephalon—Alzheimer's disease	0.00612	0.0296	CbGeAlD
Etomidate—GABRA1—forebrain—Alzheimer's disease	0.00587	0.0284	CbGeAlD
Etomidate—Arrhythmia—Galantamine—Alzheimer's disease	0.00583	0.0193	CcSEcCtD
Etomidate—GABRA1—telencephalon—Alzheimer's disease	0.0054	0.0261	CbGeAlD
Etomidate—CYP19A1—forebrain—Alzheimer's disease	0.00539	0.0261	CbGeAlD
Etomidate—Bradycardia—Donepezil—Alzheimer's disease	0.00515	0.0171	CcSEcCtD
Etomidate—Convulsion—Galantamine—Alzheimer's disease	0.00492	0.0163	CcSEcCtD
Etomidate—Hypertension—Galantamine—Alzheimer's disease	0.00491	0.0162	CcSEcCtD
Etomidate—Bradycardia—Memantine—Alzheimer's disease	0.00468	0.0155	CcSEcCtD
Etomidate—Bradycardia—Rivastigmine—Alzheimer's disease	0.00458	0.0151	CcSEcCtD
Etomidate—Tachycardia—Galantamine—Alzheimer's disease	0.00453	0.015	CcSEcCtD
Etomidate—Arrhythmia—Donepezil—Alzheimer's disease	0.00452	0.015	CcSEcCtD
Etomidate—Hypotension—Galantamine—Alzheimer's disease	0.00433	0.0143	CcSEcCtD
Etomidate—Arrhythmia—Memantine—Alzheimer's disease	0.0041	0.0136	CcSEcCtD
Etomidate—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00402	0.0133	CcSEcCtD
Etomidate—Pethidine—GRIN2B—Alzheimer's disease	0.0039	0.203	CrCbGaD
Etomidate—Ephedrine—ACHE—Alzheimer's disease	0.00383	0.199	CrCbGaD
Etomidate—Convulsion—Donepezil—Alzheimer's disease	0.00382	0.0126	CcSEcCtD
Etomidate—Hypertension—Donepezil—Alzheimer's disease	0.0038	0.0126	CcSEcCtD
Etomidate—GABRB2—nervous system—Alzheimer's disease	0.00361	0.0175	CbGeAlD
Etomidate—GABRG2—nervous system—Alzheimer's disease	0.00361	0.0175	CbGeAlD
Etomidate—GABRG2—central nervous system—Alzheimer's disease	0.00348	0.0168	CbGeAlD
Etomidate—GABRB2—central nervous system—Alzheimer's disease	0.00348	0.0168	CbGeAlD
Etomidate—Convulsion—Memantine—Alzheimer's disease	0.00347	0.0115	CcSEcCtD
Etomidate—Hypertension—Memantine—Alzheimer's disease	0.00345	0.0114	CcSEcCtD
Etomidate—GABRG2—cerebellum—Alzheimer's disease	0.0034	0.0164	CbGeAlD
Etomidate—GABRB2—cerebellum—Alzheimer's disease	0.0034	0.0164	CbGeAlD
Etomidate—Convulsion—Rivastigmine—Alzheimer's disease	0.00339	0.0112	CcSEcCtD
Etomidate—Hypertension—Rivastigmine—Alzheimer's disease	0.00338	0.0112	CcSEcCtD
Etomidate—Hypotension—Donepezil—Alzheimer's disease	0.00336	0.0111	CcSEcCtD
Etomidate—GABRA1—nervous system—Alzheimer's disease	0.00319	0.0154	CbGeAlD
Etomidate—Tachycardia—Memantine—Alzheimer's disease	0.00319	0.0105	CcSEcCtD
Etomidate—Tachycardia—Rivastigmine—Alzheimer's disease	0.00312	0.0103	CcSEcCtD
Etomidate—Pain—Donepezil—Alzheimer's disease	0.00307	0.0102	CcSEcCtD
Etomidate—GABRA1—central nervous system—Alzheimer's disease	0.00307	0.0149	CbGeAlD
Etomidate—Hypotension—Memantine—Alzheimer's disease	0.00305	0.0101	CcSEcCtD
Etomidate—GABRA1—cerebellum—Alzheimer's disease	0.003	0.0145	CbGeAlD
Etomidate—Hypotension—Rivastigmine—Alzheimer's disease	0.00298	0.00988	CcSEcCtD
Etomidate—Vomiting—Galantamine—Alzheimer's disease	0.00295	0.00976	CcSEcCtD
Etomidate—CYP19A1—nervous system—Alzheimer's disease	0.00293	0.0142	CbGeAlD
Etomidate—CYP19A1—central nervous system—Alzheimer's disease	0.00282	0.0136	CbGeAlD
Etomidate—Pain—Memantine—Alzheimer's disease	0.00279	0.00924	CcSEcCtD
Etomidate—GABRG2—brain—Alzheimer's disease	0.00276	0.0134	CbGeAlD
Etomidate—GABRB2—brain—Alzheimer's disease	0.00276	0.0134	CbGeAlD
Etomidate—Pain—Rivastigmine—Alzheimer's disease	0.00273	0.00904	CcSEcCtD
Etomidate—GABRA1—brain—Alzheimer's disease	0.00244	0.0118	CbGeAlD
Etomidate—Vomiting—Donepezil—Alzheimer's disease	0.00229	0.00757	CcSEcCtD
Etomidate—Ephedrine—BCHE—Alzheimer's disease	0.00225	0.117	CrCbGaD
Etomidate—CYP19A1—brain—Alzheimer's disease	0.00224	0.0108	CbGeAlD
Etomidate—Vomiting—Memantine—Alzheimer's disease	0.00208	0.00687	CcSEcCtD
Etomidate—Vomiting—Rivastigmine—Alzheimer's disease	0.00203	0.00672	CcSEcCtD
Etomidate—Fenoprofen—PTGS1—Alzheimer's disease	0.00189	0.0982	CrCbGaD
Etomidate—Pseudoephedrine—TNF—Alzheimer's disease	0.00165	0.0861	CrCbGaD
Etomidate—Pethidine—SLC6A4—Alzheimer's disease	0.00138	0.0717	CrCbGaD
Etomidate—Pseudoephedrine—SLC6A4—Alzheimer's disease	0.00133	0.0693	CrCbGaD
Etomidate—Fenoprofen—PTGS2—Alzheimer's disease	0.00108	0.0561	CrCbGaD
Etomidate—Pethidine—CYP2D6—Alzheimer's disease	0.000969	0.0504	CrCbGaD
Etomidate—Pseudoephedrine—CYP2D6—Alzheimer's disease	0.000936	0.0487	CrCbGaD
Etomidate—CYP19A1—Metabolism—PLD3—Alzheimer's disease	0.00019	0.000402	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	0.00019	0.000402	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—SST—Alzheimer's disease	0.000188	0.000399	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	0.000188	0.000398	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR6—Alzheimer's disease	0.000187	0.000396	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—MTHFR—Alzheimer's disease	0.000186	0.000395	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000186	0.000395	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—INPP5D—Alzheimer's disease	0.000186	0.000394	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR5—Alzheimer's disease	0.000186	0.000394	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MAOB—Alzheimer's disease	0.000185	0.000391	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TF—Alzheimer's disease	0.000184	0.00039	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—APP—Alzheimer's disease	0.000183	0.000389	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	0.000183	0.000388	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HSD17B10—Alzheimer's disease	0.000182	0.000386	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Alzheimer's disease	0.000182	0.000386	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	0.000181	0.000383	CbGpPWpGaD
Etomidate—SLC2A1—Disease—GSK3B—Alzheimer's disease	0.000179	0.00038	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—CREB1—Alzheimer's disease	0.000179	0.000378	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CREB1—Alzheimer's disease	0.000178	0.000377	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000178	0.000377	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GAPDH—Alzheimer's disease	0.000178	0.000376	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000178	0.000376	CbGpPWpGaD
Etomidate—SLC2A1—Disease—INS—Alzheimer's disease	0.000177	0.000375	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CDK5—Alzheimer's disease	0.000176	0.000374	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000176	0.000372	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP46A1—Alzheimer's disease	0.000175	0.000371	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CALM1—Alzheimer's disease	0.000174	0.000369	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000174	0.000369	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—Alzheimer's disease	0.000174	0.000368	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ACHE—Alzheimer's disease	0.000173	0.000367	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CAV1—Alzheimer's disease	0.000172	0.000364	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—A2M—Alzheimer's disease	0.000172	0.000363	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INPP5D—Alzheimer's disease	0.000171	0.000363	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR6—Alzheimer's disease	0.00017	0.00036	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ND1—Alzheimer's disease	0.000169	0.000359	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000169	0.000357	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—GAB2—Alzheimer's disease	0.000168	0.000357	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000168	0.000357	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CALM1—Alzheimer's disease	0.000167	0.000353	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000167	0.000353	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000165	0.000351	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—APP—Alzheimer's disease	0.000164	0.000348	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—CREB1—Alzheimer's disease	0.000163	0.000346	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ENO1—Alzheimer's disease	0.000162	0.000344	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS1—Alzheimer's disease	0.000162	0.000344	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000159	0.000338	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP2D6—Alzheimer's disease	0.000159	0.000337	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	0.000158	0.000335	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000156	0.00033	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	0.000155	0.000329	CbGpPWpGaD
Etomidate—SLC2A1—Disease—NOS3—Alzheimer's disease	0.000155	0.000329	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GAL—Alzheimer's disease	0.000155	0.000329	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000153	0.000324	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000151	0.000321	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PPARG—Alzheimer's disease	0.000151	0.00032	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BCHE—Alzheimer's disease	0.000151	0.00032	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ACHE—Alzheimer's disease	0.000149	0.000316	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—INS—Alzheimer's disease	0.000148	0.000314	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INPP5D—Alzheimer's disease	0.000148	0.000313	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000146	0.000309	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000143	0.000303	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—CREB1—Alzheimer's disease	0.000143	0.000303	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PLCB1—Alzheimer's disease	0.000142	0.000302	CbGpPWpGaD
Etomidate—SLC2A1—Disease—PTGS2—Alzheimer's disease	0.000142	0.000301	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GAL—Alzheimer's disease	0.000141	0.000299	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS1—Alzheimer's disease	0.00014	0.000296	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ENO1—Alzheimer's disease	0.00014	0.000296	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.00014	0.000296	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ABCA1—Alzheimer's disease	0.000138	0.000292	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TTR—Alzheimer's disease	0.000137	0.000291	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP2D6—Alzheimer's disease	0.000137	0.000291	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000137	0.00029	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SOD1—Alzheimer's disease	0.000134	0.000283	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000133	0.000283	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.00013	0.000276	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—BCHE—Alzheimer's disease	0.00013	0.000275	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—NOS3—Alzheimer's disease	0.00013	0.000275	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF2—Alzheimer's disease	0.000127	0.000269	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PLCB1—Alzheimer's disease	0.000123	0.00026	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000122	0.000259	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NPY—Alzheimer's disease	0.000122	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000122	0.000258	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR5—Alzheimer's disease	0.000121	0.000257	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000121	0.000257	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.00012	0.000255	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PYY—Alzheimer's disease	0.00012	0.000255	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARGC1A—Alzheimer's disease	0.000119	0.000252	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ABCA1—Alzheimer's disease	0.000119	0.000252	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—PTGS2—Alzheimer's disease	0.000119	0.000252	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000119	0.000252	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—HTR2A—Alzheimer's disease	0.000119	0.000252	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—HMOX1—Alzheimer's disease	0.000118	0.000251	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CRH—Alzheimer's disease	0.000118	0.000249	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	0.000117	0.000249	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000117	0.000247	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PRKCG—Alzheimer's disease	0.000114	0.000243	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—NPS—Alzheimer's disease	0.000112	0.000236	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPY—Alzheimer's disease	0.000111	0.000235	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IAPP—Alzheimer's disease	0.00011	0.000233	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—TPI1—Alzheimer's disease	0.000109	0.000231	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CHAT—Alzheimer's disease	0.000109	0.000231	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—LPL—Alzheimer's disease	0.000108	0.000229	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CRH—Alzheimer's disease	0.000107	0.000226	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000106	0.000225	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—SST—Alzheimer's disease	0.000106	0.000225	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MAOB—Alzheimer's disease	0.000105	0.000222	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CDK5—Alzheimer's disease	0.000104	0.000221	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—F2—Alzheimer's disease	0.000104	0.000221	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—APP—Alzheimer's disease	0.000104	0.00022	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	0.000103	0.000219	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—Alzheimer's disease	0.000103	0.000217	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARGC1A—Alzheimer's disease	0.000102	0.000217	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—HMOX1—Alzheimer's disease	0.000102	0.000216	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—NPS—Alzheimer's disease	0.000101	0.000215	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000101	0.000214	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GAPDH—Alzheimer's disease	0.000101	0.000213	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR6—Alzheimer's disease	0.0001	0.000212	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—PLAU—Alzheimer's disease	0.0001	0.000212	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	9.95e-05	0.000211	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	9.91e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CALM1—Alzheimer's disease	9.91e-05	0.00021	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	9.88e-05	0.000209	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	9.86e-05	0.000209	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PLCB1—Alzheimer's disease	9.78e-05	0.000207	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CAV1—Alzheimer's disease	9.78e-05	0.000207	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—MTHFR—Alzheimer's disease	9.75e-05	0.000207	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—A2M—Alzheimer's disease	9.72e-05	0.000206	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GAB2—Alzheimer's disease	9.66e-05	0.000205	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—SST—Alzheimer's disease	9.66e-05	0.000205	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	9.49e-05	0.000201	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—APP—Alzheimer's disease	9.42e-05	0.000199	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—LPL—Alzheimer's disease	9.33e-05	0.000198	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—F2—Alzheimer's disease	9.31e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL2—Alzheimer's disease	9.28e-05	0.000197	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS2—Alzheimer's disease	9.2e-05	0.000195	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CALM1—Alzheimer's disease	9.11e-05	0.000193	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PSENEN—Alzheimer's disease	9.11e-05	0.000193	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—Alzheimer's disease	9.08e-05	0.000192	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CAV1—Alzheimer's disease	8.99e-05	0.000191	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APH1A—Alzheimer's disease	8.98e-05	0.00019	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PLCB1—Alzheimer's disease	8.88e-05	0.000188	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NCSTN—Alzheimer's disease	8.74e-05	0.000185	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.67e-05	0.000184	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LRP1—Alzheimer's disease	8.53e-05	0.000181	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ACHE—Alzheimer's disease	8.46e-05	0.000179	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—MTHFR—Alzheimer's disease	8.4e-05	0.000178	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INPP5D—Alzheimer's disease	8.36e-05	0.000177	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GFAP—Alzheimer's disease	8.33e-05	0.000176	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAL—Alzheimer's disease	8.33e-05	0.000176	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IGF1—Alzheimer's disease	8.16e-05	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS1—Alzheimer's disease	7.93e-05	0.000168	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ENO1—Alzheimer's disease	7.93e-05	0.000168	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PPARG—Alzheimer's disease	7.91e-05	0.000167	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CALM1—Alzheimer's disease	7.85e-05	0.000166	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—APOE—Alzheimer's disease	7.82e-05	0.000166	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP2D6—Alzheimer's disease	7.77e-05	0.000165	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—INS—Alzheimer's disease	7.75e-05	0.000164	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CAV1—Alzheimer's disease	7.75e-05	0.000164	CbGpPWpGaD
Etomidate—SLC2A1—Disease—IL6—Alzheimer's disease	7.74e-05	0.000164	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—NOS3—Alzheimer's disease	7.39e-05	0.000157	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCHE—Alzheimer's disease	7.37e-05	0.000156	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—A2M—Alzheimer's disease	7.34e-05	0.000155	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—PRKCG—Alzheimer's disease	7.24e-05	0.000153	CbGpPWpGaD
Etomidate—SLC2A1—Disease—AKT1—Alzheimer's disease	7.14e-05	0.000151	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PSEN2—Alzheimer's disease	7.11e-05	0.000151	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PLCB1—Alzheimer's disease	6.95e-05	0.000147	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR5—Alzheimer's disease	6.86e-05	0.000145	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	6.82e-05	0.000144	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PPARG—Alzheimer's disease	6.81e-05	0.000144	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—NOS3—Alzheimer's disease	6.8e-05	0.000144	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ABCA1—Alzheimer's disease	6.74e-05	0.000143	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—HTR2A—Alzheimer's disease	6.71e-05	0.000142	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—INS—Alzheimer's disease	6.68e-05	0.000142	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	6.59e-05	0.00014	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PRKCG—Alzheimer's disease	6.57e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPY—Alzheimer's disease	6.54e-05	0.000139	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IAPP—Alzheimer's disease	6.5e-05	0.000138	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CRH—Alzheimer's disease	6.31e-05	0.000134	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR5—Alzheimer's disease	6.23e-05	0.000132	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—PTGS2—Alzheimer's disease	6.22e-05	0.000132	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—HTR2A—Alzheimer's disease	6.09e-05	0.000129	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NPS—Alzheimer's disease	5.98e-05	0.000127	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—AKT1—Alzheimer's disease	5.98e-05	0.000127	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PPP3CA—Alzheimer's disease	5.95e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—F2—Alzheimer's disease	5.88e-05	0.000125	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTK2B—Alzheimer's disease	5.87e-05	0.000124	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—NOS3—Alzheimer's disease	5.86e-05	0.000124	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARGC1A—Alzheimer's disease	5.81e-05	0.000123	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—HMOX1—Alzheimer's disease	5.78e-05	0.000122	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SST—Alzheimer's disease	5.71e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GAB2—Alzheimer's disease	5.71e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NTRK2—Alzheimer's disease	5.71e-05	0.000121	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CALM1—Alzheimer's disease	5.68e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GSK3A—Alzheimer's disease	5.66e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APP—Alzheimer's disease	5.56e-05	0.000118	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—PTGS2—Alzheimer's disease	5.36e-05	0.000114	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—F2—Alzheimer's disease	5.34e-05	0.000113	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—VEGFA—Alzheimer's disease	5.33e-05	0.000113	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—LPL—Alzheimer's disease	5.29e-05	0.000112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PLCB1—Alzheimer's disease	5.25e-05	0.000111	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGFR—Alzheimer's disease	4.9e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TGFB1—Alzheimer's disease	4.89e-05	0.000104	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CREB1—Alzheimer's disease	4.87e-05	0.000103	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ADAM10—Alzheimer's disease	4.78e-05	0.000101	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—MTHFR—Alzheimer's disease	4.76e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL2—Alzheimer's disease	4.76e-05	0.000101	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—S100B—Alzheimer's disease	4.52e-05	9.58e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CALM1—Alzheimer's disease	4.45e-05	9.42e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—Alzheimer's disease	4.43e-05	9.39e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CAV1—Alzheimer's disease	4.39e-05	9.3e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF2—Alzheimer's disease	4.31e-05	9.12e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1R—Alzheimer's disease	4.16e-05	8.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—TP53—Alzheimer's disease	4.03e-05	8.53e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LPL—Alzheimer's disease	3.99e-05	8.46e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MEF2C—Alzheimer's disease	3.96e-05	8.38e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PRKCG—Alzheimer's disease	3.88e-05	8.22e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PPARG—Alzheimer's disease	3.86e-05	8.18e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—INS—Alzheimer's disease	3.79e-05	8.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NGF—Alzheimer's disease	3.78e-05	8.01e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR5—Alzheimer's disease	3.68e-05	7.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—HTR2A—Alzheimer's disease	3.6e-05	7.63e-05	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—AKT1—Alzheimer's disease	3.4e-05	7.2e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CALM1—Alzheimer's disease	3.36e-05	7.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—Alzheimer's disease	3.35e-05	7.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LEP—Alzheimer's disease	3.35e-05	7.09e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—NOS3—Alzheimer's disease	3.32e-05	7.04e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CAV1—Alzheimer's disease	3.32e-05	7.02e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—ESR1—Alzheimer's disease	3.19e-05	6.77e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—F2—Alzheimer's disease	3.16e-05	6.69e-05	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—AKT1—Alzheimer's disease	3.13e-05	6.62e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOTCH1—Alzheimer's disease	3.09e-05	6.54e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—PTGS2—Alzheimer's disease	3.04e-05	6.43e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GSK3B—Alzheimer's disease	2.9e-05	6.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CREB1—Alzheimer's disease	2.87e-05	6.09e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—INS—Alzheimer's disease	2.86e-05	6.06e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL2—Alzheimer's disease	2.81e-05	5.96e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	2.77e-05	5.86e-05	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—AKT1—Alzheimer's disease	2.69e-05	5.71e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	2.51e-05	5.31e-05	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.15e-05	4.55e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	2.13e-05	4.51e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	2.11e-05	4.48e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	1.96e-05	4.14e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	1.95e-05	4.13e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	1.81e-05	3.83e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	1.66e-05	3.51e-05	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—AKT1—Alzheimer's disease	1.53e-05	3.23e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.36e-05	2.89e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.25e-05	2.65e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-05	2.44e-05	CbGpPWpGaD
